Medication and supplement use for managing joint symptoms among patients with knee and hip osteoarthritis: a cross-sectional study

被引:5
作者
Driban, Jeffrey B. [1 ]
Boehret, Sara A. [2 ]
Balasubramanian, Easwaran [3 ]
Cattano, Nicole M. [4 ]
Glutting, Joseph [5 ]
Sitler, Michael R. [6 ]
机构
[1] Tufts Med Ctr, Div Rheumatol, Boston, MA 02111 USA
[2] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA
[3] Temple Univ, Dept Orthopaed Surg & Sports Med, Philadelphia, PA 19140 USA
[4] W Chester Univ Penn, Dept Sports Med, W Chester, PA 19383 USA
[5] Univ Delaware, Sch Educ, Newark, DE 19716 USA
[6] Temple Univ, Coll Hlth Profess & Social Work, Philadelphia, PA 19140 USA
关键词
Prescription Medication; Complex Regional Pain Syndrome; Multiple Medication; Joint Symptom; Health History Questionnaire;
D O I
10.1186/1471-2474-13-47
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Background: The purpose was to determine the professionally-guided and self-guided medication and supplement use for joint symptom management among patients with knee and/or hip osteoarthritis (OA) in an urban hospital-based outpatient orthopedic practice. Methods: The study design was cross-sectional. Patients diagnosed by radiographs and clinical symptoms with knee and/or hip OA were recruited from an inner-city hospital-based outpatient orthopaedic office. A total of 184 patients were queried for their participation. Four investigator-generated, interview-based questionnaires were used. Sampling error was +/- 7.84%. Logistic regression models and Fisher Exact Tests were performed to determine factors that may be associated with negative behaviors related to medication or supplement use (e. g., reporting medication as ineffective, using multiple medications in the same day to manage symptoms). Odds ratios (OR) and 95% confidence intervals (CI) were calculated for significant findings. Results: Among the 162 participants, a majority reported professionally-guided recommendations and over 40% reported at least one self-guided intervention. 37 participants reported dual-use during the same day, and among those, 15 reported dual-use at the same time. Among participants taking multiple interventions in the same day, 40.5% reported using prescription and over-the-counter medications. Use of multiple medications or supplements in one day was more common among participants who reported OA at multiple joints (OR [95% CI] = 2.48 [1.03 to 5.96]) but less common among participants who did not complete high school (OR [95% CI] = 0.26 [0.08 to 0.83]). Of the 15 participants who reported dual-use at the same time, 11 were professionally-guided, 5 were professional and self-guided, and 1 was solely self-guided. Overall, 28% of participants reported their intervention as ineffective, sought an alternative method to achieve symptomatic relief, or were prescribed a stronger medication. Participants who reported not always taking their medication consistently for 2 weeks were more likely to report their medication as ineffective (OR [95% CI] = 2.87 [1.19 to 6.92]). Conclusions: Both professional and self-guided medications and supplements are used by inner city OA patients to manage their joint symptoms. It is important for clinicians to discuss with these patients how to effectively manage multiple joint symptoms, the importance of taking medications as prescribed, and what they should if they believe a treatment is ineffective or their medication runs out.
引用
收藏
页数:8
相关论文
共 13 条
[1]
Self-care and professionally guided care in Osteoarthritis - Racial differences in a population-based sample [J].
Albert, Steven M. ;
Musa, Donald ;
Kwoh, C. Kent ;
Hanlon, Joseph T. ;
Silverman, Myrna .
JOURNAL OF AGING AND HEALTH, 2008, 20 (02) :198-216
[2]
Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905
[3]
Clark N.M., 1991, J AGING HEALTH, V3, P3, DOI [DOI 10.1177/089826439100300101, 10.1177/089826439100300101]
[4]
A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain [J].
Doherty, Michael ;
Hawkey, Chris ;
Goulder, Michael ;
Gibb, Iain ;
Hill, Nicola ;
Aspley, Sue ;
Reader, Sandie .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (09) :1534-1541
[5]
Hardy George E Jr, 2004, Prev Chronic Dis, V1, pA04
[6]
Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein - The Johnston County Osteoarthritis Project [J].
Jordan, JM ;
Luta, G ;
Stabler, T ;
Renner, JB ;
Dragomir, AD ;
Vilim, V ;
Hochberg, MC ;
Helmick, CG ;
Kraus, VB .
ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :675-681
[7]
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) [J].
Jordan, KM ;
Arden, NK ;
Doherty, M ;
Bannwarth, B ;
Bijlsma, JWJ ;
Dieppe, P ;
Gunther, K ;
Hauselmann, H ;
Herrero-Beaumont, G ;
Kaklamanis, P ;
Lohmander, S ;
Leeb, B ;
Lequesne, M ;
Mazieres, B ;
Martin-Mola, E ;
Pavelka, K ;
Pendleton, A ;
Punzi, L ;
Serni, U ;
Swoboda, B ;
Verbruggen, G ;
Zimmerman-Gorska, I ;
Dougados, M .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (12) :1145-1155
[8]
Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs [J].
Kovac, Stacey H. ;
Saag, Kenneth G. ;
Curtis, Jeffrey R. ;
Allison, Jeroan .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (02) :227-233
[9]
OARSI-FDA initiative: defining the disease state of osteoarthritis [J].
Lane, N. E. ;
Brandt, K. ;
Hawker, G. ;
Peeva, E. ;
Schreyer, E. ;
Tsuji, W. ;
Hochberg, M. C. .
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (05) :478-482
[10]
Lawson B, 2004, CAN FAM PHYSICIAN, V50, P1664